Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refra...
Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Controlled Trial
About this item
Full title
Author / Creator
Zelenetz, Andrew D. , Barrientos, Jacqueline C. , Brown, Jennifer R. , Coiffier, Bertrand , Delgado, Julio , Egyed, Miklós , Ghia, Paolo , Illés, Árpád , Jurczak, Wojciech , Marlton, Paula , Montillo, Marco , Morschhauser, Franck , Pristupa, Alexander S. , Robak, Tadeusz , Sharman, Jeff P. , Simpson, David , Smolej, Lukáš , Tausch, Eugen , Adewoye, Adeboye H. , Dreiling, Lyndah K. , Kim, Yeonhee , Stilgenbauer, Stephan and Hillmen, Peter
Journal title
Language
English
Formats
More information
Alternative Titles
Full title
Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Controlled Trial
Authors, Artists and Contributors
Author / Creator
Barrientos, Jacqueline C.
Brown, Jennifer R.
Coiffier, Bertrand
Delgado, Julio
Egyed, Miklós
Ghia, Paolo
Illés, Árpád
Jurczak, Wojciech
Marlton, Paula
Montillo, Marco
Morschhauser, Franck
Pristupa, Alexander S.
Robak, Tadeusz
Sharman, Jeff P.
Simpson, David
Smolej, Lukáš
Tausch, Eugen
Adewoye, Adeboye H.
Dreiling, Lyndah K.
Kim, Yeonhee
Stilgenbauer, Stephan
Hillmen, Peter
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5589180
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5589180
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(16)30671-4
